BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ho W, Gao M, Li F, Li Z, Zhang XQ, Xu X. Next-Generation Vaccines: Nanoparticle-Mediated DNA and mRNA Delivery. Adv Healthc Mater 2021;10:e2001812. [PMID: 33458958 DOI: 10.1002/adhm.202001812] [Cited by in Crossref: 74] [Cited by in F6Publishing: 75] [Article Influence: 37.0] [Reference Citation Analysis]
Number Citing Articles
1 Wang F, Cai R, Tan W. Self-Powered Biosensor for a Highly Efficient and Ultrasensitive Dual-Biomarker Assay. Anal Chem 2023. [PMID: 36976790 DOI: 10.1021/acs.analchem.3c00097] [Reference Citation Analysis]
2 Zhang Q, Wang M, Han C, Wen Z, Meng X, Qi D, Wang N, Du H, Wang J, Lu L, Ge X. Intraduodenal Delivery of Exosome-Loaded SARS-CoV-2 RBD mRNA Induces a Neutralizing Antibody Response in Mice. Vaccines 2023;11:673. [DOI: 10.3390/vaccines11030673] [Reference Citation Analysis]
3 Hu M, Feng C, Yuan Q, Liu C, Ge B, Sun F, Zhu X. Lantern-shaped flexible RNA origami for Smad4 mRNA delivery and growth suppression of colorectal cancer. Nat Commun 2023;14:1307. [PMID: 36894556 DOI: 10.1038/s41467-023-37020-y] [Reference Citation Analysis]
4 Zhong Y, Du S, Dong Y. mRNA delivery in cancer immunotherapy. Acta Pharmaceutica Sinica B 2023. [DOI: 10.1016/j.apsb.2023.03.001] [Reference Citation Analysis]
5 Xian H, Zhang Y, Yu C, Wang Y. Nanobiotechnology-Enabled mRNA Stabilization. Pharmaceutics 2023;15. [PMID: 36839942 DOI: 10.3390/pharmaceutics15020620] [Reference Citation Analysis]
6 Chen H, Liu Z, Yue K, Ding J, He Y. Immune microenvironment: novel perspectives on bone regeneration disorder in osteoradionecrosis of the jaws. Cell Tissue Res 2023. [PMID: 36737519 DOI: 10.1007/s00441-023-03743-z] [Reference Citation Analysis]
7 Gote V, Bolla PK, Kommineni N, Butreddy A, Nukala PK, Palakurthi SS, Khan W. A Comprehensive Review of mRNA Vaccines. Int J Mol Sci 2023;24. [PMID: 36769023 DOI: 10.3390/ijms24032700] [Reference Citation Analysis]
8 Aziz T, Nadeem AA, Sarwar A, Perveen I, Hussain N, Khan AA, Daudzai Z, Cui H, Lin L. Particle Nanoarchitectonics for Nanomedicine and Nanotherapeutic Drugs with Special Emphasis on Nasal Drugs and Aging. Biomedicines 2023;11. [PMID: 36830891 DOI: 10.3390/biomedicines11020354] [Reference Citation Analysis]
9 Puhl DL, Funnell JL, Fink TD, Swaminathan A, Oudega M, Zha RH, Gilbert RJ. Electrospun fiber-mediated delivery of neurotrophin-3 mRNA for neural tissue engineering applications. Acta Biomater 2023;155:370-85. [PMID: 36423820 DOI: 10.1016/j.actbio.2022.11.025] [Reference Citation Analysis]
10 Subhan MA, Torchilin VP. Biopolymer-Based Nanosystems for siRNA Drug Delivery to Solid Tumors including Breast Cancer. Pharmaceutics 2023;15. [PMID: 36678782 DOI: 10.3390/pharmaceutics15010153] [Reference Citation Analysis]
11 Miller S, Moos W, Munk B, Munk S, Hart C, Spellmeyer D. Drug discovery: Standing on the shoulders of giants. Managing the Drug Discovery Process 2023. [DOI: 10.1016/b978-0-12-824304-6.00001-8] [Reference Citation Analysis]
12 Corrêa-Netto C, Strauch MA, Monteiro-Machado M, Teixeira-Araújo R, Fonseca JG, Leitão-Araújo M, Machado-Alves ML, Sanz L, Calvete JJ, Melo PA, Zingali RB. Monoclonal-Based Antivenomics Reveals Conserved Neutralizing Epitopes in Type I PLA(2) Molecules from Coral Snakes. Toxins (Basel) 2022;15. [PMID: 36668835 DOI: 10.3390/toxins15010015] [Reference Citation Analysis]
13 Afzal O, Altamimi ASA, Nadeem MS, Alzarea SI, Almalki WH, Tariq A, Mubeen B, Murtaza BN, Iftikhar S, Riaz N, Kazmi I. Nanoparticles in Drug Delivery: From History to Therapeutic Applications. Nanomaterials (Basel) 2022;12. [PMID: 36558344 DOI: 10.3390/nano12244494] [Reference Citation Analysis]
14 Shah S, Famta P, Bagasariya D, Charankumar K, Sikder A, Kashikar R, Kotha AK, Chougule MB, Khatri DK, Asthana A, Raghuvanshi RS, Singh SB, Srivastava S. Tuning Mesoporous Silica Nanoparticles in Novel Avenues of Cancer Therapy. Mol Pharm 2022;19:4428-52. [PMID: 36109099 DOI: 10.1021/acs.molpharmaceut.2c00374] [Reference Citation Analysis]
15 Shaputkin ED, Nifant'ev IE, Bagrov VV, Shlyakhtin AV, Abashkin DA, Galiakberova AA, Ivchenko PV. Lipophilic poly(glycolide) blocks in morpholin-2-one-based CARTs for plasmid DNA delivery: Polymer regioregularity, sequence of lipophilic/polyamine blocks, and nanoparticle stability as factors of transfection efficiency. European Polymer Journal 2022;181:111644. [DOI: 10.1016/j.eurpolymj.2022.111644] [Reference Citation Analysis]
16 Kubo K, Takeda S, Uchida M, Maeda M, Endo N, Sugahara S, Suzuki H, Fukahori H. Lit-LAMP-DNA-vaccine for shrimp allergy prevents anaphylactic symptoms in a murine model. International Immunopharmacology 2022;113:109394. [DOI: 10.1016/j.intimp.2022.109394] [Reference Citation Analysis]
17 Li Z, Zhang XQ, Ho W, Li F, Gao M, Bai X, Xu X. Enzyme-Catalyzed One-Step Synthesis of Ionizable Cationic Lipids for Lipid Nanoparticle-Based mRNA COVID-19 Vaccines. ACS Nano 2022;16:18936-50. [PMID: 36269150 DOI: 10.1021/acsnano.2c07822] [Reference Citation Analysis]
18 Bezbaruah R, Chavda VP, Nongrang L, Alom S, Deka K, Kalita T, Ali F, Bhattacharjee B, Vora L. Nanoparticle-Based Delivery Systems for Vaccines. Vaccines 2022;10:1946. [DOI: 10.3390/vaccines10111946] [Reference Citation Analysis]
19 Lin Y, Sun B, Jin Z, Zhao K. Enhanced Immune Responses to Mucosa by Functionalized Chitosan-Based Composite Nanoparticles as a Vaccine Adjuvant for Intranasal Delivery. ACS Appl Mater Interfaces 2022. [DOI: 10.1021/acsami.2c17627] [Reference Citation Analysis]
20 Wang J, Heshmati Aghda N, Jiang J, Mridula Habib A, Ouyang D, Maniruzzaman M. 3D bioprinted microparticles: Optimizing loading efficiency using advanced DoE technique and machine learning modeling. International Journal of Pharmaceutics 2022;628:122302. [DOI: 10.1016/j.ijpharm.2022.122302] [Reference Citation Analysis]
21 Xu G, Mao Y, Jiang T, Gao B, He B. Structural design strategies of microneedle-based vaccines for transdermal immunity augmentation. Journal of Controlled Release 2022;351:907-922. [DOI: 10.1016/j.jconrel.2022.10.008] [Reference Citation Analysis]
22 Toudeshkchouei MG, Tavakoli A, Mohammadghasemi H, Karimi A, Ai J, Rabiee M, Rabiee N. Recent approaches to mRNA vaccine delivery by lipid-based vectors prepared by continuous-flow microfluidic devices. Future Medicinal Chemistry 2022. [DOI: 10.4155/fmc-2022-0027] [Reference Citation Analysis]
23 Jansen EM, Frijlink HW, Hinrichs WL, Ruigrok MJ. Are inhaled mRNA vaccines safe and effective? A review of preclinical studies. Expert Opinion on Drug Delivery 2022. [DOI: 10.1080/17425247.2022.2131767] [Reference Citation Analysis]
24 Lee M, Rice-Boucher PJ, Collins LT, Wagner E, Aulisa L, Hughes J, Curiel DT. A Novel Piggyback Strategy for mRNA Delivery Exploiting Adenovirus Entry Biology. Viruses 2022;14. [PMID: 36298724 DOI: 10.3390/v14102169] [Reference Citation Analysis]
25 Wittmann C. DNA Immobilization. Encyclopedia of Analytical Chemistry 2022. [DOI: 10.1002/9780470027318.a9210.pub2] [Reference Citation Analysis]
26 Wang T, Hao B, Xu S, Meng J, Wen T, Liu J, Xu H. Effective RNAi in leukemia cells is enhanced by spermine-modified pullulan combined with desloratadine. Carbohydrate Polymers 2022;292:119646. [DOI: 10.1016/j.carbpol.2022.119646] [Reference Citation Analysis]
27 García-quiroz J, Vázquez-almazán B, García-becerra R, Díaz L, Avila E. The Interaction of Human Papillomavirus Infection and Prostaglandin E2 Signaling in Carcinogenesis: A Focus on Cervical Cancer Therapeutics. Cells 2022;11:2528. [DOI: 10.3390/cells11162528] [Reference Citation Analysis]
28 Olivera-ugarte S, Bolduc M, Laliberté-gagné M, Blanchette L, Garneau C, Fillion M, Savard P, Dubuc I, Flamand L, Farnòs O, Xu X, Kamen A, Gilbert M, Rabezanahary H, Scarrone M, Couture C, Baz M, Leclerc D. A nanoparticle-based COVID-19 vaccine candidate elicits broad neutralizing antibodies and protects against SARS-CoV-2 infection. Nanomedicine: Nanotechnology, Biology and Medicine 2022;44:102584. [DOI: 10.1016/j.nano.2022.102584] [Reference Citation Analysis]
29 Varzandeh M, Labbaf S, Varshosaz J, Laurent S. An overview of the intracellular localization of high-Z nanoradiosensitizers. Progress in Biophysics and Molecular Biology 2022. [DOI: 10.1016/j.pbiomolbio.2022.08.006] [Reference Citation Analysis]
30 Ye Q, Wu M, Zhou C, Lu X, Huang B, Zhang N, Zhao H, Chi H, Zhang X, Ling D, Zhang RR, Li Z, Luo D, Huang YJ, Qiu HY, Song H, Tan W, Xu K, Ying B, Qin CF. Rational development of a combined mRNA vaccine against COVID-19 and influenza. NPJ Vaccines 2022;7:84. [PMID: 35882870 DOI: 10.1038/s41541-022-00478-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Oluwagbemi OO, Oladipo EK, Kolawole OM, Oloke JK, Adelusi TI, Irewolede BA, Dairo EO, Ayeni AE, Kolapo KT, Akindiya OE, Ayobami OJ, Oluwadara BF, Fatumo S. Bioinformatics, Computational Informatics, and Modeling Approaches to the Design of mRNA COVID-19 Vaccine Candidates. Computation 2022;10:117. [DOI: 10.3390/computation10070117] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
32 Wang B, Moyano A, Duque JM, Sánchez L, García-santos G, Flórez LJG, Serrano-pertierra E, Blanco-lópez MDC. Nanozyme-Based Lateral Flow Immunoassay (LFIA) for Extracellular Vesicle Detection. Biosensors 2022;12:490. [DOI: 10.3390/bios12070490] [Reference Citation Analysis]
33 Ak Ç, Sayar S, Adalı G, Özdil K. Acute Severe Ulcerative Colitis After mRNA Coronavirus Disease 2019 Vaccination: Can mRNA Vaccines Unmask Inflammatory Bowel Diseases? ACG Case Rep J 2022;9:e00806. [DOI: 10.14309/crj.0000000000000806] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Liu XY, Zhang X, Yang JB, Wu CY, Wang Q, Lu ZL, Tang Q. Multifunctional amphiphilic peptide dendrimer as nonviral gene vectors for effective cancer therapy via combined gene/photodynamic therapies. Colloids Surf B Biointerfaces 2022;217:112651. [PMID: 35759892 DOI: 10.1016/j.colsurfb.2022.112651] [Reference Citation Analysis]
35 Conforti A, Salvatori E, Lione L, Compagnone M, Pinto E, Shorrock C, Hayward JA, Sun Y, Liang BM, Palombo F, Viscount B, Aurisicchio L. Linear DNA amplicons as a novel cancer vaccine strategy. J Exp Clin Cancer Res 2022;41:195. [PMID: 35668533 DOI: 10.1186/s13046-022-02402-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
36 Lim SA, Cox A, Tung M, Chung EJ. Clinical progress of nanomedicine-based RNA therapies. Bioactive Materials 2022;12:203-13. [DOI: 10.1016/j.bioactmat.2021.10.018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
37 Qin S, Tang X, Chen Y, Chen K, Fan N, Xiao W, Zheng Q, Li G, Teng Y, Wu M, Song X. mRNA-based therapeutics: powerful and versatile tools to combat diseases. Signal Transduct Target Ther 2022;7:166. [PMID: 35597779 DOI: 10.1038/s41392-022-01007-w] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 33.0] [Reference Citation Analysis]
38 Yamada Y, Ishizuka S, Arai M, Maruyama M, Harashima H. Recent advances in delivering RNA-based therapeutics to mitochondria. Expert Opin Biol Ther 2022;:1-11. [PMID: 35543589 DOI: 10.1080/14712598.2022.2070427] [Reference Citation Analysis]
39 Feng C, Li Y, Ferdows BE, Patel DN, Ouyang J, Tang Z, Kong N, Chen E, Tao W. Emerging vaccine nanotechnology: From defense against infection to sniping cancer. Acta Pharm Sin B 2022;12:2206-23. [PMID: 35013704 DOI: 10.1016/j.apsb.2021.12.021] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
40 Briones A, Martos G, Bedu M, Choteau T, Josephs RD, Wielgosz RI, Ryadnov MG. An SI-traceable reference material for virus-like particles. iScience 2022;25:104294. [DOI: 10.1016/j.isci.2022.104294] [Reference Citation Analysis]
41 Hussain A, Yang H, Zhang M, Liu Q, Alotaibi G, Irfan M, He H, Chang J, Liang XJ, Weng Y, Huang Y. mRNA vaccines for COVID-19 and diverse diseases. J Control Release 2022;345:314-33. [PMID: 35331783 DOI: 10.1016/j.jconrel.2022.03.032] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 19.0] [Reference Citation Analysis]
42 Nazary Abrbekoh F, Salimi L, Saghati S, Amini H, Fathi Karkan S, Moharamzadeh K, Sokullu E, Rahbarghazi R. Application of microneedle patches for drug delivery; doorstep to novel therapies. J Tissue Eng 2022;13:204173142210853. [DOI: 10.1177/20417314221085390] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
43 Dayie TK, Olenginski LT, Taiwo KM. Isotope Labels Combined with Solution NMR Spectroscopy Make Visible the Invisible Conformations of Small-to-Large RNAs. Chem Rev 2022. [PMID: 35442658 DOI: 10.1021/acs.chemrev.1c00845] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 Soraci L, Lattanzio F, Soraci G, Gambuzza ME, Pulvirenti C, Cozza A, Corsonello A, Luciani F, Rezza G. COVID-19 Vaccines: Current and Future Perspectives. Vaccines 2022;10:608. [DOI: 10.3390/vaccines10040608] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
45 Nafian F, Nafian S, Soleymani G, Pourmanouchehri Z, Kiyanjam M, Berenji Jalaei S, Jeyroudi H, Mohammad Mohammdi S. Perspective Chapter: Next-Generation Vaccines Based on Self-Amplifying RNA. Vaccine Development 2022. [DOI: 10.5772/intechopen.101467] [Reference Citation Analysis]
46 Tai W, Zhang X, Yang Y, Zhu J, Du L. Advances in mRNA and other vaccines against MERS-CoV. Transl Res 2022;242:20-37. [PMID: 34801748 DOI: 10.1016/j.trsl.2021.11.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
47 Belete TM. The Immune Response, Safety, and Efficacy of Emergency Use Authorization-Granted COVID-19 Vaccines: A Review. TOMICROJ 2022;16:e187428582201240. [DOI: 10.2174/18742858-v16-e2201240] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
48 Chen W, Ma Y, Liu X, Zhu D. Polyester materials for mRNA delivery. Exploration of Targeted Anti-tumor Therapy. [DOI: 10.37349/etat.2022.00075] [Reference Citation Analysis]
49 Byun MJ, Lim J, Kim S, Park D, Kim T, Park W, Park CG. Advances in Nanoparticles for Effective Delivery of RNA Therapeutics. BioChip J. [DOI: 10.1007/s13206-022-00052-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
50 Polaka S, Makwana V, Vasdev N, Sheth A, Rajpoot K, Sengupta P, Tekade RK. Engineering immunity via skin-directed drug delivery devices. Journal of Controlled Release 2022. [DOI: 10.1016/j.jconrel.2022.03.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
51 Conforti A, Salvatori E, Lione L, Compagnone M, Pinto E, Shorrock C, Hayward JA, Sun Y, Liang BM, Palombo F, Viscount B, Aurisicchio L. Linear DNA amplicons as a novel cancer vaccine strategy.. [DOI: 10.1101/2022.02.09.479777] [Reference Citation Analysis]
52 Milder FJ, Jongeneelen M, Ritschel T, Bouchier P, Bisschop IJM, de Man M, Veldman D, Le L, Kaufmann B, Bakkers MJG, Juraszek J, Brandenburg B, Langedijk JPM. Universal stabilization of the influenza hemagglutinin by structure-based redesign of the pH switch regions. Proc Natl Acad Sci USA 2022;119:e2115379119. [DOI: 10.1073/pnas.2115379119] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
53 Cox A, Lim SA, Chung EJ. Strategies to deliver RNA by nanoparticles for therapeutic potential. Mol Aspects Med 2022;83:100991. [PMID: 34366123 DOI: 10.1016/j.mam.2021.100991] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
54 Li Y, Zhang R, Xu Z, Wang Z. Advances in Nanoliposomes for the Diagnosis and Treatment of Liver Cancer. IJN 2022;Volume 17:909-25. [DOI: 10.2147/ijn.s349426] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
55 Sharma S. Role of nanomedicine in COVID-19 therapeutics. Nanomedicine (Lond) 2022. [PMID: 35012366 DOI: 10.2217/nnm-2021-0358] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
56 Tabarzad M, Mohit E, Ghorbani-bidkorbeh F. Nanovaccines delivery approaches against infectious diseases. Emerging Nanomaterials and Nano-Based Drug Delivery Approaches to Combat Antimicrobial Resistance 2022. [DOI: 10.1016/b978-0-323-90792-7.00002-6] [Reference Citation Analysis]
57 Conforti A, Palombo F, Aurisicchio L. Nucleic acid-based vaccines. Cancer Vaccines as Immunotherapy of Cancer 2022. [DOI: 10.1016/b978-0-12-823901-8.00002-9] [Reference Citation Analysis]
58 Ouranidis A, Vavilis T, Mandala E, Davidopoulou C, Stamoula E, Markopoulou CK, Karagianni A, Kachrimanis K. mRNA Therapeutic Modalities Design, Formulation and Manufacturing under Pharma 4.0 Principles. Biomedicines 2022;10:50. [DOI: 10.3390/biomedicines10010050] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
59 Cordeiro AS, Patil-Sen Y, Shivkumar M, Patel R, Khedr A, Elsawy MA. Nanovaccine Delivery Approaches and Advanced Delivery Systems for the Prevention of Viral Infections: From Development to Clinical Application. Pharmaceutics 2021;13:2091. [PMID: 34959372 DOI: 10.3390/pharmaceutics13122091] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
60 Stephan MT. Empowering patients from within: Emerging nanomedicines for in vivo immune cell reprogramming. Semin Immunol 2021;:101537. [PMID: 34844835 DOI: 10.1016/j.smim.2021.101537] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
61 Arjunan A, Robinson J, Baroutaji A, Tuñón-Molina A, Martí M, Serrano-Aroca Á. 3D Printed Cobalt-Chromium-Molybdenum Porous Superalloy with Superior Antiviral Activity. Int J Mol Sci 2021;22:12721. [PMID: 34884526 DOI: 10.3390/ijms222312721] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
62 Takayama K, Tuñón-Molina A, Cano-Vicent A, Muramoto Y, Noda T, Aparicio-Collado JL, Sabater I Serra R, Martí M, Serrano-Aroca Á. Non-Woven Infection Prevention Fabrics Coated with Biobased Cranberry Extracts Inactivate Enveloped Viruses Such as SARS-CoV-2 and Multidrug-Resistant Bacteria. Int J Mol Sci 2021;22:12719. [PMID: 34884521 DOI: 10.3390/ijms222312719] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
63 Zafar A, Hasan M, Tariq T, Dai Z. Enhancing Cancer Immunotherapeutic Efficacy with Sonotheranostic Strategies. Bioconjug Chem 2021. [PMID: 34793138 DOI: 10.1021/acs.bioconjchem.1c00437] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
64 Machado BAS, Hodel KVS, Fonseca LMDS, Mascarenhas LAB, Andrade LPCDS, Rocha VPC, Soares MBP, Berglund P, Duthie MS, Reed SG, Badaró R. The Importance of RNA-Based Vaccines in the Fight against COVID-19: An Overview. Vaccines (Basel) 2021;9:1345. [PMID: 34835276 DOI: 10.3390/vaccines9111345] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
65 Iyer S, Yadav R, Agarwal S, Tripathi S, Agarwal R. Bioengineering Strategies for Developing Vaccines against Respiratory Viral Diseases. Clin Microbiol Rev 2021;:e0012321. [PMID: 34788128 DOI: 10.1128/CMR.00123-21] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
66 Echeverría N, Comas V, Aldunate F, Perbolianachis P, Moreno P, Cristina J. In the era of rapid mRNA-based vaccines: Why is there no effective hepatitis C virus vaccine yet? World J Hepatol 2021;13:1234-68. [PMID: 34786164 DOI: 10.4254/wjh.v13.i10.1234] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
67 Kumar US, Afjei R, Ferrara K, Massoud TF, Paulmurugan R. Gold-Nanostar-Chitosan-Mediated Delivery of SARS-CoV-2 DNA Vaccine for Respiratory Mucosal Immunization: Development and Proof-of-Principle. ACS Nano 2021. [PMID: 34705425 DOI: 10.1021/acsnano.1c05002] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 10.5] [Reference Citation Analysis]
68 Huber HF, Jaberi-Douraki M, DeVader S, Aparicio-Lopez C, Nava-Chavez J, Xu X, Millagaha Gedara NI, Gaudreault NN, Delong RK. Targeting SARS-CoV-2 Variants with Nucleic Acid Therapeutic Nanoparticle Conjugates. Pharmaceuticals (Basel) 2021;14:1012. [PMID: 34681236 DOI: 10.3390/ph14101012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
69 Ahire ED, Kshirsagar SJ. Immune responses induced by different vaccine platforms against coronavirus disease-19. Explor Immunol 2021. [DOI: 10.37349/ei.2021.00016] [Reference Citation Analysis]
70 Kulagina N, Besseau S, Godon C, Goldman GH, Papon N, Courdavault V. Yeasts as Biopharmaceutical Production Platforms. Front Fungal Biol 2021;2:733492. [DOI: 10.3389/ffunb.2021.733492] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
71 Rinoldi C, Zargarian SS, Nakielski P, Li X, Liguori A, Petronella F, Presutti D, Wang Q, Costantini M, De Sio L, Gualandi C, Ding B, Pierini F. Nanotechnology-Assisted RNA Delivery: From Nucleic Acid Therapeutics to COVID-19 Vaccines. Small Methods 2021;5:2100402. [PMID: 34514087 DOI: 10.1002/smtd.202100402] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 12.0] [Reference Citation Analysis]
72 Senapati S, Upadhyaya A, Dhruw S, Giri D, Maiti P. Controlled DNA Delivery Using Poly(lactide) Nanoparticles and Understanding the Binding Interactions. J Phys Chem B 2021;125:10009-17. [PMID: 34436883 DOI: 10.1021/acs.jpcb.1c06520] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
73 Celis-Giraldo CT, López-Abán J, Muro A, Patarroyo MA, Manzano-Román R. Nanovaccines against Animal Pathogens: The Latest Findings. Vaccines (Basel) 2021;9:988. [PMID: 34579225 DOI: 10.3390/vaccines9090988] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
74 Rabiei M, Kashanian S, Samavati SS, Derakhshankhah H, Jamasb S, McInnes SJP. Characteristics of SARS-CoV2 that may be useful for nanoparticle pulmonary drug delivery. J Drug Target 2021;:1-11. [PMID: 34415800 DOI: 10.1080/1061186X.2021.1971236] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
75 Tuñón-molina A, Cano-vicent A, Martí M, Muramoto Y, Noda T, Takayama K, Serrano-aroca Á. Next generation infection prevention clothing: Non-woven Fabrics Coated with Cranberry Extracts Capable of Inactivating Enveloped Viruses such as SARS-CoV-2 and Multidrug-resistant Bacteria.. [DOI: 10.1101/2021.08.14.456330] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
76 Sharma D, Arora S, Singh J, Layek B. A review of the tortuous path of nonviral gene delivery and recent progress. Int J Biol Macromol 2021;183:2055-73. [PMID: 34087309 DOI: 10.1016/j.ijbiomac.2021.05.192] [Cited by in Crossref: 19] [Cited by in F6Publishing: 9] [Article Influence: 9.5] [Reference Citation Analysis]
77 Chan Y, Ng SW, Singh SK, Gulati M, Gupta G, Chaudhary SK, Hing GB, Collet T, MacLoughlin R, Löbenberg R, Oliver BG, Chellappan DK, Dua K. Revolutionizing polymer-based nanoparticle-linked vaccines for targeting respiratory viruses: A perspective. Life Sci 2021;280:119744. [PMID: 34174324 DOI: 10.1016/j.lfs.2021.119744] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
78 Silva AJD, de Macêdo LS, Leal LRS, de Jesus ALS, Freitas AC. Yeasts as a promising delivery platform for DNA and RNA vaccines. FEMS Yeast Res 2021;21:foab018. [PMID: 33837785 DOI: 10.1093/femsyr/foab018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
79 Niculescu AG, Chircov C, Bîrcă AC, Grumezescu AM. Nanomaterials Synthesis through Microfluidic Methods: An Updated Overview. Nanomaterials (Basel) 2021;11:864. [PMID: 33800636 DOI: 10.3390/nano11040864] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 20.0] [Reference Citation Analysis]
80 Song M, Liu C, Chen S, Zhang W. Nanocarrier-Based Drug Delivery for Melanoma Therapeutics. Int J Mol Sci 2021;22:1873. [PMID: 33668591 DOI: 10.3390/ijms22041873] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]